Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome

Clinical and Experimental Nephrology

Volumn 15, Issue 6, 2011, Pages 933-936

  Amemiya, Nobuyuki ^a   Takei, Takashi ^a   Kojima, Chiari ^a   Nokiba, Hirohiko ^a   Itabashi, Mitsuyo ^a   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Frequently relapsing minimal change nephrotic syndrome; Monotherapy; Rituximab

Indexed keywords

CYCLOSPORIN A; LOW DENSITY LIPOPROTEIN; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB;

ADULT; APHERESIS; ARTICLE; CASE REPORT; CELL COUNT; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MAINTENANCE DRUG DOSE; MALE; MINIMAL CHANGE NEPHROTIC SYNDROME; MONOTHERAPY; NEPHROTIC SYNDROME; REMISSION; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CYCLOSPORINE; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; MALE; NEPHROSIS, LIPOID; PREDNISOLONE; RECURRENCE; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84855254706     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0510-5     Document Type: Article

References (11)

1. R Cunard CJ Kelly 2002 T cells and minimal change disease J Am Soc Nephrol 13 1409 1411 11961031 10.1097/01.ASN.0000016406.82019.B3 (Pubitemid 34441424)
2. H François E Daugas A Bensman P Ronco 2006 Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations Am J Kidney Dis 49 1 158 161 10.1053/j.ajkd.2006.10.015 (Pubitemid 44932200)
3. Y Sawara M Itabashi C Kojima H Tabata D Kamei K Kawanishi, et al. 2009 Successful therapeutic use of a single-dose of rituximab on relapse in adults with minimal change nephritic syndrome Clin Nephrol 72 69 72 19640390 1:CAS:528:DC%2BD1MXhtV2jurbJ
4. K Benz J Dotsch W Rascher D Stachel 2004 Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy Pediatr Nephrol 19 794 797 15071769 10.1007/s00467-004-1434-z (Pubitemid 38931165)
5. MD Pescoviz BK Book RA Sider 2006 Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment N Engl J Med 354 1961 1963 10.1056/NEJMc055495 (Pubitemid 43872718)
6. RD Gilbert E Hulse S Rigden 2006 Rituximab therapy for steroid-dependent minimal change nephrotic syndrome Pediatr Nephrol 21 1698 1700 16932900 10.1007/s00467-006-0228-x (Pubitemid 44390835)
7. GC Smith 2007 Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome? Pediatr Nephrol 22 893 898 17310362 10.1007/s00467-006-0427-5 (Pubitemid 46629628)
8. V Guigonis A Dallocchio V Baudouin M Dehennault C Hachon-Le Camus M Afanetti, et al. 2008 Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases Pediatr Nephrol 23 1269 1279 18465150 10.1007/s00467-008-0814-1
9. H Mansour L Cheval JM Elalouf JC Aude MA Alyanakian B Mougenot, et al. 2005 T-cell transcriptome analysis points up a thymic disorder in idiopathic nephrotic syndrome Kidney Int 67 2168 2177 15882260 10.1111/j.1523-1755.2005. 00322.x 1:CAS:528:DC%2BD2MXlsFyjtLY%3D (Pubitemid 41623378)
10. HK Yap W Cheung B Murugasu SK Sim CC Seah SC Jordan 1999 Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse J Am Soc Nephrol 10 529 537 10073603 1:STN:280:DyaK1M7ntFKisw%3D%3D (Pubitemid 29117634)
11. RJ Johnson A Hurtado J Merszei B Rodriguez-Iturbe L Feng 2003 Hypothesis: dysregulation of immunologic balance resulting from hygiene and socioeconomic factors may influence the epidemiology and cause of glomerulonephritis worldwide Am J Kidney Dis 42 575 581 12955687 10.1016/S0272-6386(03)00801-1 (Pubitemid 37048135)